Right now, no. You cannot make a viable human baby without sperm. Every birth in human history has required genetic material from both a male and a female parent, and current technology cannot change that. But the science is advancing faster than most people realize, and researchers have already produced living mice from two mothers with no father involved. Here’s why sperm is still essential for humans, what scientists are working on, and how close we actually are to changing the equation.
Why Human Embryos Need a Father’s DNA
The reason isn’t just that sperm carries half the chromosomes. It’s about how those chromosomes are labeled. In mammals, certain genes are chemically tagged so that only the copy from one parent is active. The copy from the other parent is silenced. This system, called genomic imprinting, means your body relies on the mother’s version of some genes and the father’s version of others. You need both sets working correctly, or development falls apart.
When researchers have created mouse embryos using only maternal DNA (two egg cells, no sperm), those embryos develop poor placental tissue and stall out. Embryos made from only paternal DNA do the opposite: they over-develop the placenta and support structures while the embryo itself barely forms. Neither type survives. Studies in human cells have confirmed that this same parent-specific programming is conserved in our species. Losing the paternal contribution on chromosome 15, for instance, causes Prader-Willi syndrome. Losing the maternal contribution at the same spot causes Angelman syndrome. The two copies of your DNA are not interchangeable.
What Happens When an Egg Tries on Its Own
Human eggs occasionally begin dividing without sperm in a process called parthenogenesis. It happens spontaneously in the ovary, but it never produces a baby. Instead, these self-activating cells either break down or develop into an ovarian teratoma, a type of tumor that can contain fragments of hair, teeth, or bone. The embryo cannot develop to term because it lacks paternal gene imprints and is growing in the wrong location entirely. Parthenogenesis works in some reptiles, fish, and birds, but mammalian imprinting makes it a biological dead end for humans.
Mice Born From Two Mothers
In one of the most striking experiments in reproductive biology, researchers in China produced living mice from two female parents. The trick was genetically engineering the DNA from one mother to mimic the imprinting patterns normally contributed by a father. In recent work, scientists introduced targeted edits at 20 key imprinted gene regions, including frameshift mutations, gene deletions, and regulatory changes. Some of these mice survived to adulthood.
The success rate was low. But the fact that it worked at all proved something important: the barrier to sperm-free reproduction in mammals isn’t the sperm cell itself. It’s the chemical labeling on the DNA inside it. If you can replicate that labeling, the embryo doesn’t “know” the difference. Researchers also created functional placentas for embryos from two fathers by modifying a specific cluster of genes that controls placental development.
Lab-Grown Eggs and Sperm From Skin Cells
A parallel line of research called in vitro gametogenesis (IVG) is working toward creating functional eggs or sperm from ordinary body cells like skin or blood. Scientists take these cells, reprogram them into stem cells, and then coax the stem cells down the path toward becoming reproductive cells.
This has already been done fully in mice. Researchers have reconstituted the entire process of egg formation in a dish from mouse stem cells and used those eggs to produce live pups. The same has been achieved for sperm production. In humans, progress has been slower but steady. Scientists have successfully guided human stem cells through early stages of development into precursor germ cells. They’ve also gotten human egg precursor cells to enter meiosis (the special cell division that creates eggs and sperm) and form structures resembling primordial follicles in lab culture.
The hardest remaining challenges are completing meiosis reliably, maintaining genetic integrity throughout the process, and accurately resetting the imprinting marks in a sex-specific way. That last point circles back to the same core problem: getting the parental labels right. In the body, this epigenetic resetting happens naturally during germ cell development. In a dish, scientists haven’t yet replicated it faithfully in human cells.
How Close Is This to Reality
Matt Krisiloff, who leads a company funding IVG research, has speculated that the first lab-derived human egg or sperm cell could be achieved within a few years. But producing a cell in a dish and using it to create a pregnancy are very different milestones. Even after a functional human gamete is made, years of safety research, genetic validation, and regulatory review would follow before any clinical trial.
For context, the mouse breakthroughs took over a decade to go from proof of concept to repeatable results, and mouse reproduction is far simpler to study. A realistic timeline for human IVG entering clinical testing is difficult to pin down, but most researchers in the field frame it as a matter of decades, not years.
What About Three-Parent Babies?
You may have heard of “three-parent babies,” a technique approved in the UK to prevent mitochondrial diseases. This involves transferring the nuclear DNA from a mother’s egg into a donor egg that has healthy mitochondria. But this technique still requires sperm. The egg is fertilized normally after the transfer. The “third parent” contributes only mitochondrial DNA (about 37 genes), not a replacement for the father’s genetic contribution. It doesn’t remove sperm from the equation.
The Regulatory Landscape
Even as the science progresses, legal frameworks haven’t caught up. In the UK, lab-grown gametes fall into a regulatory gap. Current laws govern embryos created from eggs and sperm, but IVG-derived embryos don’t fit neatly into those definitions, meaning new legislation would likely be needed before any clinical use. In the United States, there is no specific federal regulation governing synthetic embryo research. The federal government simply won’t fund it, and most researchers voluntarily follow a 14-day limit on embryo culture, but that’s a guideline, not a law. Some countries ban the research outright.
Stem cell-derived embryo models (sometimes called synthetic embryos) add another layer of complexity. Because no egg or sperm is involved in creating them, they technically fall outside existing rules about embryo experimentation. Researchers have kept these structures alive for nearly nine days, but they are not considered embryos under current legal definitions because they lack the potential to develop into a viable organism.
What This Means Practically
If you’re asking because of a personal fertility situation, the answer today is straightforward: every available reproductive technology, from IVF to mitochondrial donation to surrogacy, requires sperm from either a partner or a donor. There is no clinical method to bypass this.
If you’re asking because you’ve seen headlines about motherless or fatherless mice, those results are real but remain confined to animal research with low survival rates and extensive genetic engineering. The biological principle that mammalian development requires both maternal and paternal genomic contributions holds firm in humans. Scientists are chipping away at the technical barriers, and the mouse experiments show those barriers are not absolute laws of nature. But translating this work to humans safely is one of the most complex challenges in reproductive biology.